TTrialPathMatch Me to Trials
← Back to trials
RecruitingObstructive Sleep Apnea

Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea

Eligible age

3–11 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This research study is designed to learn, first, whether two anesthetics have different effects on collapse seen within the upper airway during sleep endoscopy. A second purpose is to learn whether collapse at several levels of the upper airway is associated with obstructive sleep apnea that persists after adenotonsillectomy, the surgery that removes the tonsils and adenoids.

Sponsor: Erin Kirkham

You may qualify if…

  • 1. Diagnosed with Obstructive sleep apnea (OSA) by the following criteria: Obstructive Apnea Index (OAI) ≥ 1 or Apnea Hypopnea Index (AHI) ≥ 1.5, confirmed on nocturnal, laboratory-based polysomnography within the previous 12 months scored using American Academy of Sleep Medicine pediatric criteria in an accredited sleep lab.
  • 2. Considered to be a surgical candidate for adenotonsillectomy to treat OSA by an board-certified or board-eligible otolaryngologist.
  • 3. Clinical determination by the child's otolaryngologist surgeon that the child would benefit from sleep endoscopy prior to adenotonsillectomy due to one or more reported risk factors for residual sleep apnea after surgery, which may include:
  • 1. Obese (\>95th percentile of body mass index for age)
  • 2. Severe preoperative OSA (AHI ≥10 events/hour)
  • 3. Discordance between awake physical exam (eg. small tonsils) and sleep apnea symptoms or severity;
  • 4. African American race
  • 5. Age ≥7 years old

You may not qualify if…

  • 1. Previous adenotonsillectomy or other upper airway surgery (including tracheostomy) with the exception of isolated adenoidectomy if it occurred \>18 months prior to recruitment.
  • 2. Major medical diagnosis that may be exacerbated by the study treatment, pose undue risk to the patient, or that may impact interpretation of study results
  • 3. History of allergic reaction to or contraindication to receiving propofol, dexmedetomidine, ketamine or sevoflurane
  • 4. Allergy to eggs, egg products, soybeans or soybean products.
  • 5. Contraindication to receiving general anesthesia

Where it's recruiting

Michigan

Ann Arbor

Source: ClinicalTrials.gov · NCT05303987 · last updated 2026-05-14